K-ras mutation | p16 alterations | |||||
---|---|---|---|---|---|---|
Mutated | Not mutated | Methylated | LOH2-a | Deletionb | ||
All patients | 22/41 | 19/41 | 34/41 | 8/41 | 2/41 | |
Staging 2-c | ||||||
Stage I | 1 | 1 | 1 | 1 | — | |
Stage II | 2 | 4 | 4 | 2 | 1 | |
Stage IIIA | 11 | 10 | 18 | 3 | 1 | |
Stage IIIB | 2 | 1 | 3 | 1 | — | |
Stage IVA | 6 | 3 | 8 | 1 | — | |
pT category2-c | ||||||
pT1 | 1 | — | 1 | — | — | |
pT2 | 2 | 5 | 4 | 3 | 1 | |
pT3 | 13 | 11 | 21 | 4 | 1 | |
pT4 | 6 | 3 | 8 | 1 | — | |
pN category2-c | ||||||
pN0 | 17 | 15 | 26 | 6 | 2 | |
pN1 | 5 | 4 | 8 | 2 | — | |
Grading | ||||||
G1 | 9 | 5 | 11 | 3 | 1 | |
G2 | 11 | 10 | 17 | 4 | 1 | |
G3 | 2 | 4 | 6 | 1 | — |